Trial
NCT05022303
AT1001 for the Treatment of COVID-19 Related MIS-C
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
Covid19
Intervention
Larazotide Acetate
Why stopped
Decline in MISC cases
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-13